These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 11464278)
1. The periodic down regulation of Cyclin E gene expression from exit of mitosis to end of G(1) is controlled by a deacetylase- and E2F-associated bipartite repressor element. Polanowska J; Fabbrizio E; Le Cam L; Trouche D; Emiliani S; Herrera R; Sardet C Oncogene; 2001 Jul; 20(31):4115-27. PubMed ID: 11464278 [TBL] [Abstract][Full Text] [Related]
2. Timing of cyclin E gene expression depends on the regulated association of a bipartite repressor element with a novel E2F complex. Le Cam L; Polanowska J; Fabbrizio E; Olivier M; Philips A; Ng Eaton E; Classon M; Geng Y; Sardet C EMBO J; 1999 Apr; 18(7):1878-90. PubMed ID: 10202151 [TBL] [Abstract][Full Text] [Related]
4. Down-regulation of cyclin A gene expression upon genotoxic stress correlates with reduced binding of free E2F to the promoter. Spitkovsky D; Schulze A; Boye B; Jansen-Dürr P Cell Growth Differ; 1997 Jun; 8(6):699-710. PubMed ID: 9186003 [TBL] [Abstract][Full Text] [Related]
5. The COOH-terminal region of pRb2/p130 binds to histone deacetylase 1 (HDAC1), enhancing transcriptional repression of the E2F-dependent cyclin A promoter. Stiegler P; De Luca A; Bagella L; Giordano A Cancer Res; 1998 Nov; 58(22):5049-52. PubMed ID: 9823308 [TBL] [Abstract][Full Text] [Related]
6. The p107 tumor suppressor induces stable E2F DNA binding to repress target promoters. O'Connor RJ; Schaley JE; Feeney G; Hearing P Oncogene; 2001 Apr; 20(15):1882-91. PubMed ID: 11313936 [TBL] [Abstract][Full Text] [Related]
7. Down-regulation of p300/CBP histone acetyltransferase activates a senescence checkpoint in human melanocytes. Bandyopadhyay D; Okan NA; Bales E; Nascimento L; Cole PA; Medrano EE Cancer Res; 2002 Nov; 62(21):6231-9. PubMed ID: 12414652 [TBL] [Abstract][Full Text] [Related]
8. Regulation of cyclin E transcription by E2Fs and retinoblastoma protein. Geng Y; Eaton EN; Picón M; Roberts JM; Lundberg AS; Gifford A; Sardet C; Weinberg RA Oncogene; 1996 Mar; 12(6):1173-80. PubMed ID: 8649818 [TBL] [Abstract][Full Text] [Related]
9. Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter. Araki K; Nakajima Y; Eto K; Ikeda MA Oncogene; 2003 Oct; 22(48):7632-41. PubMed ID: 14576826 [TBL] [Abstract][Full Text] [Related]
10. Regulation of E2F-1 gene expression in avian cells. Espanel X; Le Cam L; North S; Sardet C; Brun G; Gillet G Oncogene; 1998 Aug; 17(5):585-94. PubMed ID: 9704924 [TBL] [Abstract][Full Text] [Related]
11. MyoD activity upregulates E2F1 and enhances transcription from the cyclin E promoter in differentiating myoblasts lacking a functional retinoblastoma protein. Tedesco D; Vesco C Exp Cell Res; 2001 Oct; 269(2):301-11. PubMed ID: 11570822 [TBL] [Abstract][Full Text] [Related]
12. The Rb/chromatin connection and epigenetic control: opinion. Ferreira R; Naguibneva I; Pritchard LL; Ait-Si-Ali S; Harel-Bellan A Oncogene; 2001 May; 20(24):3128-33. PubMed ID: 11420729 [TBL] [Abstract][Full Text] [Related]
13. Identification of a set of protein species approximately 40 kDa as high-affinity DNA binding factor(s) to the cell cycle regulatory region of the human thymidine kinase promoter. Kim EC; Rawlings SL; Li LJ; Roy B; Lee AS Cell Growth Differ; 1996 Dec; 7(12):1741-9. PubMed ID: 8959343 [TBL] [Abstract][Full Text] [Related]
14. Transcriptional control by cell-cycle regulators: a review. Lania L; Majello B; Napolitano G J Cell Physiol; 1999 May; 179(2):134-41. PubMed ID: 10199552 [TBL] [Abstract][Full Text] [Related]
15. A novel factor distinct from E2F mediates C-MYC promoter activation through its E2F element during exit from quiescence. Alvaro-Blanco J; Martínez-Gac L; Calonge E; Rodríguez-Martínez M; Molina-Privado I; Redondo JM; Alcamí J; Flemington EK; Campanero MR Carcinogenesis; 2009 Mar; 30(3):440-8. PubMed ID: 19126644 [TBL] [Abstract][Full Text] [Related]
16. Role of pRB-family/E2F complex in the inhibition of IL-3-dependent lymphoid cell proliferation. Yamada M; Kondo T; Ashizawa S; Takebayashi T; Higashi H; Hatakeyama M Cytokine; 2002 Jan; 17(2):91-7. PubMed ID: 11886176 [TBL] [Abstract][Full Text] [Related]
17. Characterization of E2F8, a novel E2F-like cell-cycle regulated repressor of E2F-activated transcription. Christensen J; Cloos P; Toftegaard U; Klinkenberg D; Bracken AP; Trinh E; Heeran M; Di Stefano L; Helin K Nucleic Acids Res; 2005; 33(17):5458-70. PubMed ID: 16179649 [TBL] [Abstract][Full Text] [Related]
19. E2F activation of S phase promoters via association with HCF-1 and the MLL family of histone H3K4 methyltransferases. Tyagi S; Chabes AL; Wysocka J; Herr W Mol Cell; 2007 Jul; 27(1):107-19. PubMed ID: 17612494 [TBL] [Abstract][Full Text] [Related]
20. The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells. Radkov SA; Kellam P; Boshoff C Nat Med; 2000 Oct; 6(10):1121-7. PubMed ID: 11017143 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]